Skip to main content

Advertisement

Log in

Anxiety and Fear-Avoidance in Musculoskeletal Pain

  • Fibromyalgia (MFP Peres, Section editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Musculoskeletal pain (MP) is common in the general population and has been associated with anxiety in several ways: (a) muscle tension is included as a part of the diagnostic criteria for generalized anxiety disorder, (b) pain can be a common symptom and a good indicator of an anxiety disorder, (c) anxiety is an independent predictor of quality of life in patients with chronic MP, (d) anxiety leads to higher levels of pain chronification, and (e) fear, anxiety, and avoidance are related to MP. The objective of this article is to explore the mechanisms underlying the relation between anxiety disorders and musculoskeletal pain as well as its management. We have also highlighted the role of spirituality and religiosity in MP treatment. We found some similarities between proposed mechanisms and explicative models for both conditions as well as an overlapping between the treatments available. The recognition of this association is important for professionals who deal with chronic pain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as:• Of importance •• Of major importance

  1. Picavet H, Schouten J. Musculoskeletal pain in The Netherlands: prevalences, consequences and risk groups, the DMC3-study. Pain. 2003;102:167–78.

    Article  PubMed  CAS  Google Scholar 

  2. Magni G, Marchetti M, Moreschi C, Merskey H, Luchini SR. Chronic musculoskeletal pain and depressive symptoms in the National Health and Nutrition Examination I. Epidemiologic follow-up study. Pain. 1993;53:163–8.

    Article  PubMed  CAS  Google Scholar 

  3. Bergman S, Herrström P, Högström K, Petersson IF, Svensson B, Jacobsson L. Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study. J Rheumatol. 2001;28:1369–77.

    PubMed  CAS  Google Scholar 

  4. Cimmino MA, Ferrone C, Cutolo M. Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol. 2011;25:173–83.

    Article  PubMed  Google Scholar 

  5. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull WHO. 2003;81:646–56.

    PubMed  Google Scholar 

  6. Carnes D, Parsons S, Ashby D, Breen A, Foster N, Pincus T, et al. Chronic musculoskeletal pain rarely presents in a single body site: results from a UK population study. Rheumatology. 2007;46:1168–70.

    Article  PubMed  CAS  Google Scholar 

  7. Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J, et al. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc. 2009;18:23–33.

    PubMed  Google Scholar 

  8. Andrews G, Hobbs MJ, Borkovec TD, Beesdo K, Craske MG, Heimberg RG, et al. Generalized worry disorder: a review of DSM-IV generalized anxiety disorder and options for DSM-V. Depress Anxiety. 2010;27:134–47.

    Article  PubMed  Google Scholar 

  9. Means-Christensen AJ, Roy-Byrne PP, Sherbourne CD, Craske MG, Stein MB. Relationships among pain, anxiety, and depression in primary care. Depress Anxiety. 2008;25:593–600.

    Article  PubMed  Google Scholar 

  10. Orenius TI, Koskela T, Koho P, Pohjolainen T, Kautiainen H, Haanpää M, et al. Anxiety and Depression Are Independent Predictors of Quality of Life of Patients with Chronic Musculoskeletal Pain. J Health Psychol. 2012; [in press].

  11. Karakurum B, Soylu Ö, Karatas M, Giray S, Tan M, Arlier Z, et al. Personality, depression, and anxiety as risk factors for chronic migraine. Int J Neurosci. 2004;114:1391–9.

    Article  PubMed  Google Scholar 

  12. Vlaeyen JWS, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain. 2000;85:317–32.

    Article  PubMed  CAS  Google Scholar 

  13. Gormsen L, Rosenberg R, Bach FW, Jensen TS. Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. Eur J Pain. 2010;14(127):e1–8.

    PubMed  Google Scholar 

  14. Pesa J, Lage MJ. The medical costs of migraine and comorbid anxiety and depression. Headache. 2004;44:562–70.

    Article  PubMed  Google Scholar 

  15. James JE, Hardardottir D. Influence of attention focus and trait anxiety on tolerance of acute pain. Br J Health Psychol. 2002;7:149–62.

    Article  PubMed  Google Scholar 

  16. Olatunji BO, Deacon BJ, Abramowitz JS. Is hypochondriasis an anxiety disorder? Br J Psychiatry. 2009;194:481–2.

    Article  PubMed  Google Scholar 

  17. Rhudy JL, Meagher MW. Fear and anxiety: divergent effects on human pain thresholds. Pain. 2000;84:65–75.

    Article  PubMed  CAS  Google Scholar 

  18. Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet. 2005;14:135–43.

    Article  PubMed  CAS  Google Scholar 

  19. Tchivileva IE, Lim PF, Smith SB, Slade GD, Diatchenko L, McLean SA, et al. Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study. Pharmacogenet Genomics. 2010;20:239–48.

    PubMed  CAS  Google Scholar 

  20. McGrath M, Kawachi I, Ascherio A, Colditz GA, Hunter DJ, De Vivo I. Association between catechol-O-methyltransferase and phobic anxiety. Am J Psychiatry. 2004;161:1703–5.

    Article  PubMed  Google Scholar 

  21. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D. Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet. 2003;13:33–41.

    Article  PubMed  Google Scholar 

  22. Montag C, Buckholtz JW, Hartmann P, Merz M, Burk C, Hennig J, et al. COMT genetic variation affects fear processing: psychophysiological evidence. Behav Neurosci. 2008;122:901–9.

    Article  PubMed  CAS  Google Scholar 

  23. Wolfe F, Russell I, Vipraio G, Ross K, Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol. 1997;24:555–9.

    PubMed  CAS  Google Scholar 

  24. Gordon JA, Hen R. The serotonergic system and anxiety. Neuro Mol Med. 2004;5:27–40.

    CAS  Google Scholar 

  25. Wood PB, Patterson JC, Sunderland JJ, Tainter KH, Glabus MF, Lilien DL. Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J Pain. 2007;8:51–8.

    Article  PubMed  CAS  Google Scholar 

  26. Nikolaus S, Antke C, Beu M, Müller HW. Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders--results from in vivo imaging studies. Rev Neurosci. 2010;21:119–39.

    Article  PubMed  CAS  Google Scholar 

  27. Shin LM, Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology. 2010;35:169–91.

    Article  PubMed  Google Scholar 

  28. Finestone HM, Alfeeli A, Fisher WA. Stress-induced physiologic changes as a basis for the biopsychosocial model of chronic musculoskeletal pain: a new theory? Clin J Pain. 2008;24:767–75.

    Article  PubMed  Google Scholar 

  29. Bingefors K, Isacson D. Epidemiology, co-morbidity, and impact on health-related quality of life of self-reported headache and musculoskeletal pain—a gender perspective. Eur J Pain. 2004;8:435–50.

    Article  PubMed  Google Scholar 

  30. Stoyanova M, Hope DA. Gender, gender roles, and anxiety: perceived confirmability of self report, behavioral avoidance, and physiological reactivity. J Anxiety Disord. 2012;26:206–14.

    Article  PubMed  Google Scholar 

  31. Gore M, Sadosky A, Stacey BR, Tai KS, Leslie D. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and healthcare costs in usual care Settings. Spine (Phila Pa 1976). 2011;Dec 3 [Epub ahead of print].

  32. Knook LME, Konijnenberg AY, van der Hoeven J, Kimpen JLL, Buitelaar JK, van Engeland H, et al. Psychiatric disorders in children and adolescents presenting with unexplained chronic pain: what is the prevalence and clinical relevancy? Eur Child Adolesc Psychiatry. 2011;20:39–48.

    Article  PubMed  Google Scholar 

  33. Asmundson GJG, Carleton RN. Fear of pain is elevated in adults with co-occurring trauma-related stress and social anxiety symptoms. Cogn Behav Ther. 2005;34:248–55.

    Article  PubMed  Google Scholar 

  34. Greenberg J, Burns JW. Pain anxiety among chronic pain patients: specific phobia or manifestation of anxiety sensitivity? Behav Res Ther. 2003;41:223–40.

    Article  PubMed  Google Scholar 

  35. • Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K. Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med. 2008;70:890–7. This study showed that the added morbidity of depression and anxiety with chronic pain is strongly associated with more severe pain, greater disability, and poorer quality of life.

    Article  PubMed  CAS  Google Scholar 

  36. Carleton R, Abrams M, Kachur S, Asmundson GJG. Waddell’s symptoms as correlates of vulnerabilities associated with fear–anxiety–avoidance models of pain: pain-related anxiety, catastrophic thinking, perceived disability, and treatment outcome. J Occup Rehabil. 2009;19:364–74.

    Article  PubMed  CAS  Google Scholar 

  37. Beneciuk JM, Bishop MD, George SZ. Pain catastrophizing predicts pain intensity during a neurodynamic test for the median nerve in healthy participants. Manual Ther. 2010;15:370–5.

    Article  Google Scholar 

  38. Jensen JC, Haahr JP, Frost P, Andersen JH. The significance of health anxiety and somatization in care-seeking for back and upper extremity pain. BMC Fam Pract. 2012;29:86–95.

    Google Scholar 

  39. Rachman S. Anxiety. UK: Psychology Press Ltd, Publishers; 1998.

    Google Scholar 

  40. Cannon WB. Bodily changes in pain, hunger, fear and rage. Appleton: Oxford; 1929.

    Google Scholar 

  41. Leeuw M, Goossens MEJB, Linton SJ, Crombez G, Boersma K, Vlaeyen JWS. The fear-avoidance model of musculoskeletal pain: current state of scientific evidence. J Behav Med. 2007;30:77–94.

    Article  PubMed  Google Scholar 

  42. Murphy D, Lindsay S, De C, Williams AC. Chronic low back pain: predictions of pain and relationship to anxiety and avoidance. Behav Res Ther. 1997;35:231–8.

    Article  PubMed  CAS  Google Scholar 

  43. White TL, Depue RA. Differential association of traits of fear and anxiety with norepinephrine-and dark-induced pupil reactivity. J Abnorm Soc Psychol. 1999;77:863–77.

    CAS  Google Scholar 

  44. Crombez G, Vlaeyen JWS, Heuts PHTG, Lysens R. Pain-related fear is more disabling than pain itself: evidence on the role of pain-related fear in chronic back pain disability. Pain. 1999;80:329–39.

    Article  PubMed  CAS  Google Scholar 

  45. Lethem J, Slade P, Troup J, Bentley G. Outline of a fear-avoidance model of exaggerated pain perception. Behav Res Ther. 1983;21:401–8.

    Article  PubMed  CAS  Google Scholar 

  46. Woolf A, Zeidler H, Haglund U, Carr A, Chaussade S, Cucinotta D, et al. Musculoskeletal pain in Europe: its impact and a comparison of population and medical perceptions of treatment in eight European countries. Ann Rheum Dis. 2004;63:342–7.

    Article  PubMed  CAS  Google Scholar 

  47. Mannerkorpi K, Henriksson C. Non-pharmacological treatment of chronic widespread musculoskeletal pain. Best Pract Res Clin Rheumatol. 2007;21:513–34.

    Article  PubMed  Google Scholar 

  48. Goldenberg DL. Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain. Best Pract Res Clin Rheumatol. 2007;21:499–511.

    Article  PubMed  CAS  Google Scholar 

  49. Nardi AE, Lopes FL, Freire RC, Veras AB, Nascimento I, Valença AM, et al. Panic disorder and social anxiety disorder subtypes in a caffeine challenge test. Psychiatry Res. 2009;169:149–53.

    Article  PubMed  Google Scholar 

  50. Hagen K, Thoresen K, Stovner LJ, Zwart JA. High dietary caffeine consumption is associated with a modest increase in headache prevalence: results from the Head-HUNT Study. J Headache Pain. 2009;10:153–9.

    Article  PubMed  CAS  Google Scholar 

  51. Sawynok J. Caffeine and pain. Pain. 2011;152:726.

    Article  PubMed  Google Scholar 

  52. Roehrs T, Roth T. Caffeine: Sleep and daytime sleepiness. Sleep Med Rev. 2008;12:153–62.

    Article  PubMed  Google Scholar 

  53. Edwards RR, Almeida DM, Klick B, Haythornthwaite JA, Smith MT. Duration of sleep contributes to next-day pain report in the general population. Pain. 2008;137:202–7.

    Article  PubMed  Google Scholar 

  54. Bigatti SM, Hernandez AM, Cronan TA, Rand KL. Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Care Res. 2008;59:961–7.

    Article  Google Scholar 

  55. van Mill JG, Hoogendijk WJG, Vogelzangs N, van Dyck R, Penninx BWJH. Insomnia and sleep duration in a large cohort of patients with major depressive disorder and anxiety disorders. J Clin Psychiatry. 2010;71:239–46.

    Article  PubMed  Google Scholar 

  56. Littlejohn G. Musculoskeletal pain. J Royal Coll Phys Edinburgh. 2005;35:340–4.

    Google Scholar 

  57. Herring MP, O'Connor PJ, Dishman RK. The effect of exercise training on anxiety symptoms among patients: a systematic review. Arch Intern Med. 2010;170:321–31.

    Article  PubMed  Google Scholar 

  58. Hofmann SG, Smits JAJ. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008;69:621–32.

    Article  PubMed  Google Scholar 

  59. Morley S, Eccleston C, Williams A. Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache. Pain. 1999;80:1–13.

    Article  PubMed  CAS  Google Scholar 

  60. Hassett AL, Gevirtz RN. Nonpharmacologic treatment for fibromyalgia: patient education, cognitive-behavioral therapy, relaxation techniques, and complementary and alternative medicine. Clin Rheum Dis. 2009;35:393–407.

    Article  Google Scholar 

  61. van der Watt G, Laugharne J, Janca A. Complementary and alternative medicine in the treatment of anxiety and depression. Curr Opin Psychiatry. 2008;21:37–42.

    Article  PubMed  Google Scholar 

  62. Lucchetti G, Lucchetti AGL, Badan-Neto AM, Peres PT, Peres MFP, Moreira-Almeida A, et al. Religiousness affects mental health, pain and quality of life in older people in an outpatient rehabilitation setting. J Rehab Med. 2011;43:316–22.

    Article  Google Scholar 

  63. Powell LH, Shahabi L, Thoresen CE. Religion and spirituality: linkages to physical health. Am Psychol. 2003;58:36–52.

    Article  PubMed  Google Scholar 

  64. Lucchetti G, Lucchetti ALG, Koenig HG. Impact of Spirituality/Religiosity on Mortality: Comparison With Other Health Interventions. Explore. 2011;7:234–8.

    Article  PubMed  Google Scholar 

  65. Koenig HG. Research on religion, spirituality, and mental health: a review. Can Psychiatr Assoc J. 2009;54:283–91.

    Google Scholar 

  66. Lucchetti G, Almeida LGC, Lucchetti ALG. Religiousness, mental health, and quality of life in Brazilian dialysis patients. Hemodialysis Int. 2012;16:89–94.

    Google Scholar 

  67. Rippentrop AE. A review of the role of religion and spirituality in chronic pain populations. Rehabil Psychol. 2005;50:278–84.

    Article  Google Scholar 

  68. •• Peres MFP, Lucchetti G. Coping strategies in chronic pain. Curr Pain Headache Reps. 2010;14:331–8. This is a comprehensive review dealing with coping in chronic pain.

    Article  Google Scholar 

  69. Mariotti L, Lucchetti G, Dantas M, Banin V, Fumelli F, Padula N. Spirituality and medicine: views and opinions of teachers in a Brazilian medical school. Med Teach. 2011;33:339–40.

    PubMed  Google Scholar 

  70. Harrison MO, Edwards CL, Koenig HG, Bosworth HB, Decastro L, Wood M. Religiosity/spirituality and pain in patients with sickle cell disease. J Nerv Ment Dis. 2005;193:250–7.

    Article  PubMed  Google Scholar 

  71. Keefe FJ, Affleck G, Lefebvre J, Underwood L, Caldwell DS, Drew J, et al. Living with rheumatoid arthritis: the role of daily spirituality and daily religious and spiritual coping. J Pain. 2001;2:101–10.

    Article  PubMed  CAS  Google Scholar 

  72. Büssing A, Michalsen A, Balzat HJ, Grünther RA, Ostermann T, Neugebauer EAM, et al. Are spirituality and religiosity resources for patients with chronic pain conditions? Pain Med. 2009;10:327–39.

    Article  PubMed  Google Scholar 

  73. Baetz M, Bowen R. Chronic pain and fatigue: associations with religion and spirituality. Pain Res Manag. 2008;13:383–8.

    PubMed  CAS  Google Scholar 

  74. Shreve-Neiger AK, Edelstein BA. Religion and anxiety: a critical review of the literature. Clin Psychol Rev. 2004;24:379–97.

    Article  PubMed  Google Scholar 

  75. Braghetta CC, Lucchetti G, Leão FC, Vallada C, Vallada H, Cordeiro Q. Ethical and legal aspects of religious assistance in psychiatric hospitals. Revista de Psiquiatria Clínica. 2011;38:189–93.

    Article  Google Scholar 

  76. Koszycki D, Raab K, Aldosary F, Bradwejn J. A multifaith spiritually based intervention for generalized anxiety disorder: a pilot randomized trial. J Clin Psychol. 2010;66:430–41.

    PubMed  Google Scholar 

  77. Ano GG, Vasconcelles EB. Religious coping and psychological adjustment to stress: a meta-analysis. J Clin Psychol. 2005;61:461–80.

    Article  PubMed  Google Scholar 

  78. Kroenke K, Krebs EE, Bair MJ. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry. 2009;31:206–19.

    Article  PubMed  Google Scholar 

  79. Arnold LM, Keck PE, Welge JA. Antidepressant treatment of fibromyalgia: a meta-analysis and review. Psychosomatics. 2000;41:104–13.

    Article  PubMed  CAS  Google Scholar 

  80. Brecht S, Courtecuisse C, Debieuvre C, Croenlein J, Desaiah D, Raskin J, et al. Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial. J Clin Psychiatry. 2007;68:1707–16.

    Article  PubMed  CAS  Google Scholar 

  81. Stein DJ, Ahokas AA, De Bodinat C. Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol. 2008;28:561–6.

    Article  PubMed  CAS  Google Scholar 

  82. Crofford LJ, Rowbotham MC, Mease PJ, Russell IJ, Dworkin RH, Corbin AE, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52:1264–73.

    Article  PubMed  CAS  Google Scholar 

  83. Arnold LM, Goldenberg DL, Stanford SB, Lalonde JK, Sandhu H, Keck Jr PE, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum. 2007;56:1336–44.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosures

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mario Fernando Prieto Peres.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lucchetti, G., Oliveira, A.B., Mercante, J.P.P. et al. Anxiety and Fear-Avoidance in Musculoskeletal Pain. Curr Pain Headache Rep 16, 399–406 (2012). https://doi.org/10.1007/s11916-012-0286-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-012-0286-7

Keywords

Navigation